Tag Archives: Targeted

FDA Approves Kesimpta (ofatumumab) Targeted B-cell Therapy for Patients with Relapsing Multiple Sclerosis

FDA Approves Kesimpta (ofatumumab) Targeted B-cell Therapy for Patients with Relapsing Multiple Sclerosis Print this page Basel, August 20, 2020 — Novartis today announced that the US Food and Drug Administration (FDA) has approved Kesimpta® (ofatumumab, formerly OMB157) as an injection for subcutaneous use for the treatment of relapsing forms of multiple sclerosis (RMS), to include clinically… Read More »

Juul Targeted Schools, Camps and Youth Programs, House Panel Claims

WASHINGTON — Last summer, with public concern about teenage vaping growing, Juul Labs paid a charter school organization in Baltimore $ 134,000 to set up a five-week summer camp to teach children healthy lifestyles. The curriculum was created by Juul — maker of the very vaping devices that were causing the most alarm among parents,… Read More »